243 related articles for article (PubMed ID: 28100188)
41. TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival.
Piras-Straub K; Khairzada K; Trippler M; Baba HA; Kaiser GM; Paul A; Canbay A; Weber F; Gerken G; Herzer K
Int J Cancer; 2015 Feb; 136(4):E154-60. PubMed ID: 25123818
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
43. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
44. Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.
Hoki T; Katsuta E; Yan L; Takabe K; Ito F
J Surg Res; 2019 Feb; 234():343-352. PubMed ID: 30527495
[TBL] [Abstract][Full Text] [Related]
45. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
46. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
47. SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.
Turato C; Vitale A; Fasolato S; Ruvoletto M; Terrin L; Quarta S; Ramirez Morales R; Biasiolo A; Zanus G; Zali N; Tan PS; Hoshida Y; Gatta A; Cillo U; Pontisso P
Br J Cancer; 2014 May; 110(11):2708-15. PubMed ID: 24809782
[TBL] [Abstract][Full Text] [Related]
48. [Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].
Han ZB; Chen HY; Fan JW; Wu JY; Peng ZH; Wang ZW
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):884-7. PubMed ID: 23863669
[TBL] [Abstract][Full Text] [Related]
49. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
50. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
[TBL] [Abstract][Full Text] [Related]
51. Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.
Yao H; Liu X; Chen S; Xia W; Chen X
Int J Clin Exp Pathol; 2015; 8(11):14830-5. PubMed ID: 26823812
[TBL] [Abstract][Full Text] [Related]
52. Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification A.
Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
Hepatogastroenterology; 2015; 62(137):164-8. PubMed ID: 25911889
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma.
Shim JH; Kang HJ; Han S; Lee YJ; Lee SG; Yu E; Lee HC
J Gastroenterol Hepatol; 2014 Mar; 29(3):524-32. PubMed ID: 23981200
[TBL] [Abstract][Full Text] [Related]
54. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
56. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
[TBL] [Abstract][Full Text] [Related]
57. Histological expression of methionine adenosyl transferase (MAT) 2A as a post-surgical prognostic surrogate in patients with hepatocellular carcinoma.
An J; Na SK; Shim JH; Park YS; Jun MJ; Lee JH; Song GW; Lee HC; Yu E
J Surg Oncol; 2018 Apr; 117(5):892-901. PubMed ID: 29448301
[TBL] [Abstract][Full Text] [Related]
58. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
[TBL] [Abstract][Full Text] [Related]
59. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
[TBL] [Abstract][Full Text] [Related]
60. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
